MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: Radiographic-pathologiccorrelation
Mg. Harisinghani et al., MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: Radiographic-pathologiccorrelation, AM J ROENTG, 172(5), 1999, pp. 1347-1351
Citations number
23
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
OBJECTIVE, The purpose of this study was to administer ultrasmall superpara
magnetic iron oxide (USPIO) and compare changes in signal intensity of lymp
h nodes in patients with primary abdominal and pelvic malignancies. Also, w
e correlated radiographic with pathologic findings.
SUBJECTS AND METHODS, Nineteen patients with proven primary abdominal or pe
lvic cancer (prostatic [n = 10]; colonic [n = 5]; endometrial [n = 1]; Merk
el cell tumor [n = 1]; lymphoma [n = 1]; seminoma [n = II) were enrolled as
part of our phase II and phase III clinical trials. In these patients, 49
lymph nodes (mean size, 1.4 cm) revealed on CT or MR imaging were evaluated
on T1-weighted spin-echo, T2-weighted fast spin-echo, and T2*- weighted gr
adient-echo MR imaging at 1.5 T 24-36 hr after IV administration of USPIO.
Quantitative analyses used measurements of unenhanced and enhanced region-o
f-interest values in lymph nodes. Qualitative assessment used subjective ev
aluation and classification of changes in signal intensity. All patients un
derwent lymph node biopsy or surgical dissection followed by histopathologi
c correlation.
RESULTS. Of the 49 lymph nodes that were evaluated, 20 were benign and 29 w
ere malignant. A decrease in nodal signal intensity on enhanced T2-weighted
and T2*-weighted gradient-echo images was seen in 20 benign lymph nodes an
d two malignant lymph nodes. No appreciable signal change was noted in 27 o
f the 29 malignant lymph nodes. The mean signal intensity on fast spin-echo
T2-weighted images for benign lymph nodes changed from 186.48 (unenhanced)
to 73.66 (enhanced). Conversely, mean signal intensity for malignant lymph
nodes was relatively unchanged from 191.17 (unenhanced) to 183.18 (enhance
d),
CONCLUSION. USPIO appears to be a useful MR contrast agent for characterizi
ng benign and malignant lymph nodes based on the enhancement criteria evalu
ated in our study.